Fund Holdings — Opaleye Management Inc.

Total Portfolio Value:
$458.86M
Total Bought:
$147.63M
Total Sold:
$84.08M
Net Transaction:
+$63.55M
Notable People:
James Aaron Silverman
Securities
▲▼
SharesValue
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Ocular Therapeutix, Inc.(OCUL)6,070,0006,653,138+583,138$27.07M$60.54M13.19%+$33.47M
Harrow, Inc.(HROW)3,820,0003,920,600+100,600$42.78M$51.87M11.30%+$9.09M
TG Therapeutics, Inc.(TGTX)2,215,0002,280,000+65,000$37.83M$34.68M7.56%-$3.15M
Keros Therapeutics, Inc.(KROS)357,500367,500+10,000$14.21M$24.33M5.30%+$10.11M
Rhythm Pharmaceuticals, Inc.(RYTM)610,000515,000-95,000$28.04M$22.31M4.86%-$5.73M
Catalyst Pharmaceuticals Inc1,257,2001,004,355-252,845$21.44M$16.01M3.49%-$5.43M
Arvinas, Inc.(ARVN)263,700330,000+66,300$10.85M$13.62M2.97%+$2.77M
Iovance Biotherapeutics, Inc.(IOVA)897,000897,0000$7.29M$13.29M2.90%+$6.00M
Jasper Therapeutics, Inc.(JSPR)0435,573+435,573$0$12.79M2.79%+$12.79M
Edgewise Therapeutics, Inc.(EWTX)699,000665,000-34,000$7.65M$12.13M2.64%+$4.48M
Applied Therapeutics1,092,5001,770,000+677,500$3.66M$12.04M2.62%+$8.38M
4d Molecular Therapeutics Inc308,500344,123+35,623$6.25M$10.96M2.39%+$4.71M
Codexis, Inc.(CDXS)3,045,5253,120,000+74,475$9.29M$10.89M2.37%+$1.60M
Protara Therapeutics, Inc.(TARA)2,692,5942,692,5940$5.05M$10.80M2.35%+$5.75M
Acelyrin Inc4,146,1381,580,000-2,566,138$30.93M$10.66M2.32%-$20.27M
Crinetics Pharmaceuticals Inc307,500210,000-97,500$10.94M$9.83M2.14%-$1.11M
Eton Pharmaceuticals, Inc.(ETON)2,529,8872,445,781-84,106$11.08M$9.17M2.00%-$1.91M
Trevi Therapeutics, Inc.(TRVI)2,535,0002,645,000+110,000$3.40M$9.13M1.99%+$5.73M
Lyell Immunopharma, Inc.(LYEL)03,355,000+3,355,000$0$7.48M1.63%+$7.48M
Newamsterdam Pharma Company
ORDINARY SHARES
265,388315,388+50,000$2.96M$7.46M1.63%+$4.49M
Ventyx Biosciences Inc1,140,0001,285,000+145,000$2.82M$7.07M1.54%+$4.25M
Intellia Therapeutics, Inc.(NTLA)99,000255,000+156,000$3.02M$7.02M1.53%+$4.00M
Compass Therapeutics, Inc.(CMPX)03,170,000+3,170,000$0$6.28M1.37%+$6.28M
Xoma Corp Del250,000250,0000$4.63M$6.01M1.31%+$1.39M
Liquidia Corporation(LQDA)445,000395,000-50,000$5.35M$5.83M1.27%+$472.9K
Vaxcyte, Inc.(PCVX)90,00085,000-5,000$5.65M$5.81M1.27%+$154.3K
Nyxoah S ASHS
SHS
344,800320,000-24,800$1.60M$4.32M0.94%+$2.72M
Savara Inc.(SVRA)0855,000+855,000$0$4.26M0.93%+$4.26M
Syros Pharmaceuticals Inc359,370787,545+428,175$2.80M$4.21M0.92%+$1.41M
UroGen Pharma Ltd.(URGN)320,000270,000-50,000$4.80M$4.05M0.88%-$750.0K
Nurix Therapeutics, Inc.67080M103(NRIX)0267,210+267,210$0$3.93M0.86%+$3.93M
Revance Therapeutics Inc0785,000+785,000$0$3.86M0.84%+$3.86M
Relmada Therapeutics, Inc.(RLMD)877,000759,000-118,000$3.63M$3.53M0.77%-$101.4K
Protagonist Therapeutics Inc112,700112,7000$2.58M$3.26M0.71%+$676.2K
Gossamer Bio, Inc.NOTE 5 000 6 0(GOSS)000$2.92M$3.21M0.70%+$297.8K
Zentalis Pharmaceuticals, Inc.(ZNTL)0200,000+200,000$0$3.15M0.69%+$3.15M
Allakos Inc02,435,000+2,435,000$0$3.07M0.67%+$3.07M
Gossamer Bio, Inc.(GOSS)2,982,2002,440,109-542,091$2.72M$2.88M0.63%+$158.1K
iBio, Inc.(IBIO)0680,000+680,000$0$2.76M0.60%+$2.76M
Verastem, Inc.(VSTM)211,400211,4000$1.72M$2.49M0.54%+$773.7K
Aligos Therapeutics Inc1,297,0001,630,000+333,000$861.2K$1.60M0.35%+$736.2K
Context Therapeutics Inc.(CNTX)975,0001,108,357+133,357$1.10M$1.53M0.33%+$427.8K
Precigen, Inc.(PGEN)1,012,500947,500-65,000$1.36M$1.37M0.30%+$17.1K
Larimar Therapeutics, Inc.(LRMR)623,500174,413-449,087$2.84M$1.32M0.29%-$1.51M
Fulcrum Therapeutics, Inc.(FULC)130,000130,0000$877.5K$1.23M0.27%+$349.7K
Morphosys AgADS145,00065,000-80,000$1.44M$1.18M0.26%-$256.4K
Glaukos Corporation(GKOS)08,576+8,576$0$808.6K0.18%+$808.6K
PMV Pharmaceuticals, Inc.(PMVP)0471,481+471,481$0$802.1K0.17%+$802.1K
Biodesix, Inc.(BDSX)496,500534,657+38,157$3.61M$764.6K0.17%-$2.85M
Regulus Therapeutics Inc0170,308+170,308$0$490.5K0.11%+$490.5K
Design Therapeutics, Inc.(DSGN)0113,038+113,038$0$455.5K0.10%+$455.5K
REPARE THERAPEUTICS iNC067,561+67,561$0$318.2K0.07%+$318.2K
Arcutis Biotherapeutics, Inc.(ARQT)1,960,0000-1,960,000$6.33M$0—-$6.33M
Biohaven Ltd.(BHVN)200,0000-200,000$8.56M$0—-$8.56M
IDEAYA Biosciences, Inc.(IDYA)311,5000-311,500$11.08M$0—-$11.08M
Jasper Therapeutics, Inc.(JSPR)3,985,3400-3,985,340$3.14M$0—-$3.14M
Kalvista Pharmaceuticals Inc150,0000-150,000$1.84M$0—-$1.84M
Kiniksa Pharmaceuticals LtdCL A37,5000-37,500$640.2K$0—-$640.2K
Marinus Pharmaceuticals Inc563,5000-563,500$6.13M$0—-$6.13M
Sutro Biopharma, Inc.(STRO)301,4910-301,491$1.29M$0—-$1.29M
Page 1 of 1
Opaleye Management Inc. — 13F Holdings — Q1 2024 | TickerTrail